Arrowstreet Capital’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $561K | Sell |
52,994
-5,601
| -10% | -$59.3K | ﹤0.01% | 1730 |
|
2025
Q1 | $881K | Sell |
58,595
-860
| -1% | -$12.9K | ﹤0.01% | 1497 |
|
2024
Q4 | $979K | Sell |
59,455
-49,338
| -45% | -$812K | ﹤0.01% | 1463 |
|
2024
Q3 | $2.69M | Hold |
108,793
| – | – | ﹤0.01% | 1153 |
|
2024
Q2 | $2.76M | Sell |
108,793
-11,026
| -9% | -$279K | ﹤0.01% | 993 |
|
2024
Q1 | $3.04M | Sell |
119,819
-102,691
| -46% | -$2.61M | ﹤0.01% | 1031 |
|
2023
Q4 | $5.04M | Buy |
222,510
+83,396
| +60% | +$1.89M | 0.01% | 748 |
|
2023
Q3 | $2.59M | Buy |
+139,114
| New | +$2.59M | ﹤0.01% | 797 |
|
2022
Q1 | – | Sell |
-29,906
| Closed | -$1.07M | – | 1176 |
|
2021
Q4 | $1.07M | Buy |
29,906
+210
| +0.7% | +$7.53K | ﹤0.01% | 1151 |
|
2021
Q3 | $1.26M | Sell |
29,696
-20,365
| -41% | -$867K | ﹤0.01% | 1242 |
|
2021
Q2 | $2.17M | Buy |
+50,061
| New | +$2.17M | ﹤0.01% | 1327 |
|
2020
Q3 | – | Sell |
-47,155
| Closed | -$1.78M | – | 2311 |
|
2020
Q2 | $1.78M | Sell |
47,155
-30,835
| -40% | -$1.16M | ﹤0.01% | 1532 |
|
2020
Q1 | $2.26M | Sell |
77,990
-129,070
| -62% | -$3.73M | 0.01% | 1022 |
|
2019
Q4 | $10.7M | Buy |
207,060
+124,973
| +152% | +$6.48M | 0.03% | 592 |
|
2019
Q3 | $4.51M | Buy |
82,087
+3,224
| +4% | +$177K | 0.01% | 736 |
|
2019
Q2 | $3.2M | Buy |
78,863
+19,300
| +32% | +$784K | 0.01% | 781 |
|
2019
Q1 | $1.8M | Buy |
+59,563
| New | +$1.8M | ﹤0.01% | 1142 |
|
2016
Q4 | – | Sell |
-26,721
| Closed | -$1.28M | – | 1624 |
|
2016
Q3 | $1.28M | Buy |
+26,721
| New | +$1.28M | ﹤0.01% | 1020 |
|
2014
Q4 | – | Sell |
-17,236
| Closed | -$632K | – | 1219 |
|
2014
Q3 | $632K | Sell |
17,236
-24,303
| -59% | -$891K | ﹤0.01% | 795 |
|
2014
Q2 | $1.93M | Buy |
41,539
+30,737
| +285% | +$1.42M | 0.01% | 599 |
|
2014
Q1 | $444K | Buy |
+10,802
| New | +$444K | ﹤0.01% | 979 |
|